$HROW.US ranked positive on December 23rd, 2022

Smart Insider $HROW.US ranked positive on December 23rd, 2022

$HROW.US ranked positive on December 23rd, 2022

Harrow Health Inc – (HROW, +1, Dec 23rd)

Four insiders bought a total of $725,000 of stock on the 21-22nd December at approx $13.40. Most notably Mark Baum (CEO since 2012, founder) bought $325,000 increasing his stake by 2% in his first clean purchase on record despite a long tenure and Martin Makary (Non-Executive since March 2022) bought $334,000 having only just joined the board. He is Chief of Islet Transplant Surgery at The Johns Hopkins Hospital.

Lawrence Horn (Director since 2020) bought $25,000 in his first buy since joining and Andrew Boll (CFO since 2015, joined 2011) bought $34,000 in his first clean purchase since joining. The company raised $25m at $10.52 on the 14th of December (Opaleye Management who are 13% shareholders bought $4.5m) which may have triggered these purchases but they do appear to be clean open-market buys.

We are ranking the stock +1.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.

If you are interested in our Stocks of the Week
those services may also be useful for you


Timely data delivery customised to every user, backed by analysis tools on our internal website


We rank the stocks where transactions are most likely to indicate future share price performance


Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top